ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 2 filers reported holding ANIKA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,966 | -33.3% | 588,629 | -7.0% | 0.02% | -20.8% |
Q2 2023 | $16,451 | -0.5% | 633,229 | +10.0% | 0.02% | +9.1% |
Q1 2023 | $16,526 | -6.3% | 575,417 | -3.4% | 0.02% | -8.3% |
Q4 2022 | $17,628 | -99.9% | 595,529 | -6.4% | 0.02% | +14.3% |
Q3 2022 | $15,149,000 | -3.8% | 636,517 | -9.8% | 0.02% | +10.5% |
Q2 2022 | $15,754,000 | -7.2% | 705,817 | +4.4% | 0.02% | -5.0% |
Q1 2022 | $16,980,000 | -30.7% | 676,217 | -1.1% | 0.02% | -33.3% |
Q4 2021 | $24,487,000 | -18.3% | 683,417 | -2.9% | 0.03% | -23.1% |
Q3 2021 | $29,963,000 | -3.7% | 704,017 | -2.0% | 0.04% | 0.0% |
Q2 2021 | $31,113,000 | +2.4% | 718,717 | -3.5% | 0.04% | +2.6% |
Q1 2021 | $30,389,000 | -17.0% | 745,017 | -7.9% | 0.04% | -5.0% |
Q4 2020 | $36,621,000 | +23.7% | 809,117 | -3.3% | 0.04% | +33.3% |
Q3 2020 | $29,604,000 | -6.0% | 836,517 | +0.2% | 0.03% | +11.1% |
Q2 2020 | $31,501,000 | +45.7% | 834,917 | +11.6% | 0.03% | +28.6% |
Q1 2020 | $21,620,000 | -28.7% | 747,829 | +27.8% | 0.02% | -8.7% |
Q4 2019 | $30,339,000 | +14.5% | 585,129 | +21.2% | 0.02% | +4.5% |
Q3 2019 | $26,508,000 | +46.9% | 482,922 | +8.7% | 0.02% | +37.5% |
Q2 2019 | $18,044,000 | +63.3% | 444,222 | +21.6% | 0.02% | +60.0% |
Q1 2019 | $11,050,000 | +24.9% | 365,410 | +38.9% | 0.01% | 0.0% |
Q4 2018 | $8,844,000 | -22.4% | 263,133 | -2.6% | 0.01% | -16.7% |
Q3 2018 | $11,394,000 | -43.6% | 270,126 | -48.0% | 0.01% | +9.1% |
Q2 2018 | $20,208,000 | +101.1% | 519,600 | +157.1% | 0.01% | 0.0% |
Q1 2018 | $10,048,000 | +69.9% | 202,100 | +84.2% | 0.01% | +57.1% |
Q4 2017 | $5,914,000 | -11.1% | 109,700 | -4.4% | 0.01% | -12.5% |
Q3 2017 | $6,653,000 | -6.9% | 114,700 | -20.8% | 0.01% | -11.1% |
Q2 2017 | $7,149,000 | -35.0% | 144,900 | -42.7% | 0.01% | -40.0% |
Q1 2017 | $10,995,000 | +34.6% | 253,100 | +51.7% | 0.02% | +15.4% |
Q4 2016 | $8,167,000 | -17.8% | 166,800 | -19.7% | 0.01% | -27.8% |
Q3 2016 | $9,938,000 | -31.7% | 207,700 | -23.4% | 0.02% | -35.7% |
Q2 2016 | $14,545,000 | +8.3% | 271,100 | -9.8% | 0.03% | +7.7% |
Q1 2016 | $13,434,000 | +211.5% | 300,400 | +165.8% | 0.03% | +188.9% |
Q4 2015 | $4,312,000 | +152.8% | 113,000 | +110.8% | 0.01% | +125.0% |
Q3 2015 | $1,706,000 | -55.9% | 53,600 | -54.3% | 0.00% | -55.6% |
Q2 2015 | $3,871,000 | -16.4% | 117,200 | +4.2% | 0.01% | -10.0% |
Q1 2015 | $4,632,000 | -46.6% | 112,500 | -47.1% | 0.01% | -52.4% |
Q4 2014 | $8,669,000 | -12.6% | 212,800 | -21.4% | 0.02% | -22.2% |
Q3 2014 | $9,920,000 | -41.7% | 270,600 | -26.3% | 0.03% | -32.5% |
Q2 2014 | $17,022,000 | -6.4% | 367,400 | -17.0% | 0.04% | -9.1% |
Q1 2014 | $18,183,000 | +20.1% | 442,400 | +11.5% | 0.04% | +22.2% |
Q4 2013 | $15,142,000 | +57.6% | 396,800 | -1.3% | 0.04% | +56.5% |
Q3 2013 | $9,606,000 | +52.4% | 402,100 | +8.5% | 0.02% | +35.3% |
Q2 2013 | $6,302,000 | – | 370,703 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |